Drugs / MDMA
last change Sep 2025 re-read 2 minutes ago

MDMA

Developed for
post-traumatic stress disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06989957 Comparator Sep 2025 → Aug 2028 expected post-traumatic stress disorder Johns Hopkins University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MDMA ClinicalTrials.gov intervention name — accepted as the source's own label NCT06989957